Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.
Abbott's strong market position, promising growth prospects and consistent share gains make it a compelling pick for investors.
Abbott (ABT) closed the most recent trading day at $114.76, moving +0.39% from the previous trading session.
The latest trading day saw Abbott (ABT) settling at $114.31, representing a +0.07% change from its previous close.
Abbott Laboratories: A Future-Driven Pharma Brand With A Robust Pipeline
It's that time of year again. I'm not referring to buying gifts and preparing holiday meals -- although that may be part of your agenda too.
Here, we have presented four healthcare technology stocks for stable portfolio gains in 2025: VCYT, OMCL, MASI and ABT.
Investors feel optimistic about Abbott's robust strength in the EPD and Nutrition businesses. Yet, unfavorable forex impacts are concerning.
Abbott completes the world's first leadless pacing procedures in the left bundle branch of the heart.
As an investor, your goal is to select quality stocks that will advance over a period of years -- but this doesn't mean you have to wait a long time for all of the rewards. If you add a few dividend stocks to your portfolio, you'll start collecting returns on a regular basis -- without lifting a finger.
In the latest trading session, Abbott (ABT) closed at $113.29, marking a +0.59% move from the previous day.
In the closing of the recent trading day, Abbott (ABT) stood at $114.14, denoting a -1.18% change from the preceding trading day.